← Back to research

Tomer Meir / Research

Data-driven COVID-19 response

During the COVID-19 pandemic, public-health decisions had to be made before all the evidence was available. At the Segal Lab, Weizmann Institute of Science (2020–2021), we devised national symptom surveys to help identify outbreak regions and developed models to prioritize testing when capacity was limited. We also developed models and analyses to help understand hospital demand, patient outcomes, and the population-level response, and studied changes in pandemic dynamics following vaccine rollout.

When hospital pressure changes patient outcomes

A central question was whether rising hospital load was associated with worse outcomes, beyond differences in who was being admitted. We combined multistate survival modeling with nationwide records of 22,636 hospitalized patients. The models represented patients’ movement between clinical states and compared observed mortality with predictions accounting for patient characteristics.

Periods with more than 500 severe or critical patients hospitalized nationally were associated with increased mortality compared with lower-load periods. This provided evidence that the consequences of hospital pressure could emerge below the official capacity threshold of 800. The finding describes an association from observational data.

National hospital burden and observed versus model-predicted COVID-19 mortality over time

Hospital burden and observed versus predicted mortality across the study period.

Publications

Hospital load and increased COVID-19 related mortality in Israel
Hagai Rossman, Tomer Meir, Jonathan Somer, Smadar Shilo, Rom Gutman, Asaf Ben Arie, Eran Segal, Uri Shalit, Malka Gorfine
Nature Communications, 2021

COVID-19 dynamics after a national immunization program in Israel
Hagai Rossman, Smadar Shilo, Tomer Meir, Malka Gorfine, Uri Shalit, Eran Segal
Nature Medicine, 2021

Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study
Carole H. Sudre, Ayya Keshet, Mark S. Graham, Amit D. Joshi, Smadar Shilo, Hagai Rossman, Benjamin Murray, Erika Molteni, Kerstin Klaser, Liane D. Canas, Michela Antonelli, Long H. Nguyen, David A. Drew, Marc Modat, Joan Capdevila Pujol, Sajaysurya Ganesh, Jonathan Wolf, Tomer Meir, Andrew T. Chan, Claire J. Steves, Tim D. Spector, John S. Brownstein, Eran Segal, Sebastien Ourselin, Christina M. Astley
The Lancet Digital Health, 2021

A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom Surveys
Saar Shoer, Tal Karady, Ayya Keshet, Smadar Shilo, Hagai Rossman, Amir Gavrieli, Tomer Meir, Amit Lavon, Dmitry Kolobkov, Iris Kalka, Anastasia Godneva, Ori Cohen, Adam Kariv, Ori Hoch, Mushon Zer-Aviv, Noam Castel, Carole Sudre, Anat Ekka Zohar, Angela Irony, Tim Spector, Benjamin Geiger, Dorit Hizi, Varda Shalev, Ran Balicer, Eran Segal
Med, 2021

Stress-related emotional and behavioural impact following the first COVID-19 outbreak peak
Asaf Benjamin, Yael Kuperman, Noa Eren, Ron Rotkopf, Maya Amitai, Hagai Rossman, Smadar Shilo, Tomer Meir, Ayya Keshet, Orit Nuttman-Shwartz, Eran Segal, Alon Chen
Molecular Psychiatry, 2021

Building an international consortium for tracking coronavirus health status
Eran Segal et al.
Nature Medicine, 2020

The effect of a national lockdown in response to COVID-19 pandemic on the prevalence of clinical symptoms in the population
Ayya Keshet, Amir Gavrieli, Hagai Rossman, Smadar Shilo, Tomer Meir, Tal Karady, Amit Lavon, Dmitry Kolobkov, Iris Kalka, Saar Shoer, Anastasia Godneva, Ori Cohen, Adam Kariv, Ori Hoch, Mushon Zer-Aviv, Noam Castel, Anat Ekka Zohar, Angela Irony, Benjamin Geiger, Yuval Dor, Dorit Hizi, Ran Balicer, Varda Shalev, Eran Segal
medRxiv preprint, 2020